- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05401331
Effect of Mask Use on Hemodynamic Responses During Exertion
August 25, 2022 updated by: Saglik Bilimleri Universitesi
The use of masks is a necessity due to the current pandemic conditions.
The aim of the study is to examine the effects of the use of masks during effort on dyspnea and fatigue with hemodynamic parameters.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The use of masks is a necessity due to the current pandemic conditions.There are studies on many parameters such as the effect of mask use on saturation (sp02), heart rate (HR) and blood pressure (BP).
To determine whether there is a change in the performance of individuals in the masked and unmasked exercise test during exertion due to the scarcity of masked and unmasked maximal exercise tests and the insufficient measurement of the degree of fatigue felt, and to determine whether there is a change in the performance of individuals with and without mask, and to determine the hemodynamic responses in the body together with dyspnea and felt fatigue.
This study will be conducted in order to examine the effect on
Study Type
Interventional
Enrollment (Actual)
52
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey, 00034
- University of Health Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 25 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Volunteering to work,
- To be healthy,
- 18-25 age range.
Exclusion Criteria:
- Unstabil angina pectoris,
- Atrial arrhythmia,
- Uncontrollable asthma,
- Pa02 < 50 mmHg,
- PaCO2> 70mmHg,
- Individuals with valve disease
- Tachycardia, bradycardia,
- Individuals with a resting systolic blood pressure of 200 mmHg
- Smoking,
- Presence of effective clinical conditions such as nasal deviation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SCREENING
- Allocation: NON_RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: Hemodynamic changes due to mask use
|
Hemodynamic changes before and after treadmill use
Other Names:
mask
|
|
OTHER: Hemodynamic responses when we do not use masks
|
Hemodynamic changes before and after treadmill use
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of blood pressure changes due to mask use
Time Frame: The period in which each participant is evaluated by taking the outcome criterion is 30-60 minutes.
|
Blood pressure reading with sphygmomanometer.
|
The period in which each participant is evaluated by taking the outcome criterion is 30-60 minutes.
|
|
Evaluation of dyspnea score
Time Frame: The period in which each participant is evaluated by taking the outcome criterion is 30-60 minutes.
|
Dyspnea score was evaluated with the Modified Borg Scale.
The Modified Borg Scale is a 0 to 10 numerical score used to measure dyspnea.
0 indicates minimum dyspnea and 10 indicates maximum dyspnea.
|
The period in which each participant is evaluated by taking the outcome criterion is 30-60 minutes.
|
|
Evaluation of the degree of perceived fatigue
Time Frame: The period in which each participant is evaluated by taking the outcome criterion is 30-60 minutes.
|
The degree of perceived fatigue was evaluated with the Modified Borg Scale.
The Modified Borg Scale was used to assess perceived difficulty.
The Modified Borg Scale is a numerical score from 0 to 10. 0 means minimum difficulty and 10 means maximum difficulty.
|
The period in which each participant is evaluated by taking the outcome criterion is 30-60 minutes.
|
|
Measurement of oxygen saturation and heart rate changes due to mask use
Time Frame: The period in which each participant is evaluated by taking the outcome criterion is 30-60 minutes.
|
Oxygen saturation and heart rate were recorded with a pulseoximetry device.
|
The period in which each participant is evaluated by taking the outcome criterion is 30-60 minutes.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Gülşah Karabıyık, Saglik Bilimleri Universitesi
- Principal Investigator: Ayşegül Tunç, Saglik Bilimleri Universitesi
- Principal Investigator: Zeynep Tanrıverdi, Saglik Bilimleri Universitesi
- Principal Investigator: Selen Öztürk, Saglik Bilimleri Universitesi
- Principal Investigator: Fulya Senem Karaahmetoğlu, Saglik Bilimleri Universitesi
- Principal Investigator: Halit Çınarka, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
April 1, 2022
Primary Completion (ACTUAL)
May 1, 2022
Study Completion (ACTUAL)
June 10, 2022
Study Registration Dates
First Submitted
April 11, 2022
First Submitted That Met QC Criteria
May 28, 2022
First Posted (ACTUAL)
June 2, 2022
Study Record Updates
Last Update Posted (ACTUAL)
August 30, 2022
Last Update Submitted That Met QC Criteria
August 25, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Mask and Hemodynamic Responses
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID-19
-
PfizerActive, not recruitingCOVID-19 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | COVID-19 Vaccines | SARS-CoV-2 Infection, COVID19 | COVID-19 Vaccination | SARS-CoV-2 Infection, COVID-19 | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionUnited States
-
Shanghai Public Health Clinical CenterNot yet recruiting
-
Duke UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)RecruitingPost COVID-19 Condition | Post COVID-19 | Post COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID-19 Condition (PCC)Germany
-
PfizerRecruitingRespiratory Tract Diseases | COVID-19 | Pneumonia | Lung Diseases | Coronavirus Disease 2019 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | Upper Respiratory Tract Infections | Respiratory Tract Infection | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionBelgium
-
ModeX Therapeutics, An OPKO Health CompanyRecruitingCOVID -19 | COVID-19 (Prevention)United States
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRecruitingFatigue | Post-COVID-19 Syndrome | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19 | Long-COVID | Post-COVID ConditionCanada
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Yang I. PachankisActive, not recruitingCOVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated StrokeChina
-
University of Missouri, Kansas CityNational Institute on Minority Health and Health Disparities (NIMHD)Active, not recruitingCOVID-19 Testing BehaviorsUnited States